Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0VF4H
|
|||
Former ID |
DAP001336
|
|||
Drug Name |
Hydroxocobalamin
|
|||
Synonyms |
AlphaRedisol; Axion; Axlon; Cobalex; Codroxomin; Cyanokit; Depogamma; Docclan; Docelan; Docelvita; Docevita; Duradoce; Hidroxocobalamina; Hydrobamine; Hydrocobalamin; Hydrogrisevit; Hydrovit; Hydroxocobalaminacetat; Hydroxocobalamine; Hydroxocobalaminum; Hydroxocobemine; Hydroxomin; Hydroxycobalamin; Hydroxycobalamine; Hyxobamine; Idrogrisevit; Idrossocobalamina; Oxobemin; Vibeden; Vitadurin; Alpha Cobione; Ciplamin H; Hydro Cobex; Hydroxocobalamin acetate; Hydroxocobalamin monohydrochloride; Hydroxy Cobal; Idrossocobalamina [DCIT]; Primabalt RP; Hydroxocobalamin Vitamin B12; Hydroxy vitamin B12; Ohb12; Vitamin B12a; Vitamin B12b; Acti-B12; AlphaRedisol (TN); Benzimidazolyl ribofuranosyl phosphate deriv.; Cyanokit (TN); Ducobee-Hy; Duralta-12; Hidroxocobalamina [INN-Spanish]; Hydroxocobalamine [INN-French]; Hydroxocobalaminum [INN-Latin]; Hydroxycob(lll)alamin; Lyovit-H; Neo-Betalin 12; Neo-cytamen; Neo-macrabin; Neo-rojamin; OH-Cbl; OH-Duphar; Oxolamine (arcum); Redisol-H; Sytobex-H; Vitamin B(sub 12a); Vitamin B-12b; Hydroxocobalamin (JAN/USP/INN); Hydroxocobalamin [USAN:INN:BAN:JAN]; Alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide; Hydroxocobalamin(alkaline soln.), OH-replaces CN-in Cyanocobalamin); Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide; Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt; Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole; Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole; Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole; Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole; Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3); Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Vitamin B12 deficiency [ICD-11: 5B5F; ICD-10: E53.8; ICD-9: 266.2] | Approved | [1] | |
Lung injury [ICD-11: NB32.3Z] | Phase 2 | [2] | ||
Therapeutic Class |
Vitamins
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C62H90CoN13O15P
|
|||
Canonical SMILES |
CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2]
|
|||
InChI |
1S/C62H90N13O14P.Co.H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;1H2/q;+2;/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1
|
|||
InChIKey |
DQOCFCZRZOAIBN-WZHZPDAFSA-L
|
|||
CAS Number |
CAS 13422-51-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ADReCS Drug ID | BADD_D01099 ; BADD_D01100 | |||
SuperDrug ATC ID |
B03BA03; V03AB33
|
|||
SuperDrug CAS ID |
cas=013422510
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Methylmalonyl-CoA mutase (MMUT) | Target Info | Cofactor | [3] |
BioCyc | Superpathway of methionine degradation | |||
Propionyl-CoA degradation | ||||
2-oxobutanoate degradation | ||||
KEGG Pathway | Valine, leucine and isoleucine degradation | |||
Glyoxylate and dicarboxylate metabolism | ||||
Propanoate metabolism | ||||
Metabolic pathways | ||||
Carbon metabolism | ||||
Panther Pathway | Methylmalonyl pathway | |||
Succinate to proprionate conversion | ||||
Pathwhiz Pathway | Valine, Leucine and Isoleucine Degradation | |||
Propanoate Metabolism | ||||
Threonine and 2-Oxobutanoate Degradation | ||||
Reactome | Cobalamin (Cbl, vitamin B12) transport and metabolism | |||
WikiPathways | Metabolism of water-soluble vitamins and cofactors | |||
Fatty acid, triacylglycerol, and ketone body metabolism | ||||
Vitamin B12 Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 085998. | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 3 | Vitamin B12. Nippon Rinsho. 1999 Oct;57(10):2205-10. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.